These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11353634)

  • 61. HIV-1 drug resistance and resistance testing.
    Clutter DS; Jordan MR; Bertagnolio S; Shafer RW
    Infect Genet Evol; 2016 Dec; 46():292-307. PubMed ID: 27587334
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Molecular epidemiology of HIV in a cohort of men having sex with men from Istanbul.
    Alpsar D; Agacfidan A; Lübke N; Verheyen J; Eraksoy H; Cağatay A; Bozkaya E; Kaiser R; Akgül B
    Med Microbiol Immunol; 2013 Jun; 202(3):251-5. PubMed ID: 23296905
    [TBL] [Abstract][Full Text] [Related]  

  • 63. HIV-1 antiretroviral resistance: scientific principles and clinical applications.
    Tang MW; Shafer RW
    Drugs; 2012 Jun; 72(9):e1-25. PubMed ID: 22686620
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Thymidine analogue excision and discrimination modulated by mutational complexes including single amino acid deletions of Asp-67 or Thr-69 in HIV-1 reverse transcriptase.
    Kisic M; Matamoros T; Nevot M; Mendieta J; Martinez-Picado J; Martínez MA; Menéndez-Arias L
    J Biol Chem; 2011 Jun; 286(23):20615-24. PubMed ID: 21504903
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparison of the Mechanisms of Drug Resistance among HIV, Hepatitis B, and Hepatitis C.
    Margeridon-Thermet S; Shafer RW
    Viruses; 2010 Dec; 2(12):2696-739. PubMed ID: 21243082
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Case report of the rare deletion at codon 69 of reverse transcriptase in a South African HIV-1 subtype C infected patient.
    Wallis CL; Venter WD; Stevens WS; Papathanasopoulos MA
    Virus Genes; 2010 Dec; 41(3):358-60. PubMed ID: 20890651
    [No Abstract]   [Full Text] [Related]  

  • 67. Clinical and genotypic findings in HIV-infected patients with the K65R mutation failing first-line antiretroviral therapy in Nigeria.
    Hawkins CA; Chaplin B; Idoko J; Ekong E; Adewole I; Gashau W; Murphy RL; Kanki P;
    J Acquir Immune Defic Syndr; 2009 Oct; 52(2):228-34. PubMed ID: 19644383
    [TBL] [Abstract][Full Text] [Related]  

  • 68. HIV-1 drug resistance mutations: an updated framework for the second decade of HAART.
    Shafer RW; Schapiro JM
    AIDS Rev; 2008; 10(2):67-84. PubMed ID: 18615118
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Ninety-nine is not enough: molecular characterization of inhibitor-resistant human immunodeficiency virus type 1 protease mutants with insertions in the flap region.
    Kozísek M; Sasková KG; Rezácová P; Brynda J; van Maarseveen NM; De Jong D; Boucher CA; Kagan RM; Nijhuis M; Konvalinka J
    J Virol; 2008 Jun; 82(12):5869-78. PubMed ID: 18400858
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Relative fitness and replication capacity of a multinucleoside analogue-resistant clinical human immunodeficiency virus type 1 isolate with a deletion of codon 69 in the reverse transcriptase coding region.
    Villena C; Prado JG; Puertas MC; Martínez MA; Clotet B; Ruiz L; Parkin NT; Menéndez-Arias L; Martinez-Picado J
    J Virol; 2007 May; 81(9):4713-21. PubMed ID: 17314158
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Human immunodeficiency virus type 1: resistance to nucleoside analogues and replicative capacity in primary human macrophages.
    Perez-Bercoff D; Wurtzer S; Compain S; Benech H; Clavel F
    J Virol; 2007 May; 81(9):4540-50. PubMed ID: 17287264
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evidence for the acquisition of multi-drug resistance in an HIV-1 clinical isolate via human sequence transduction.
    Takebe Y; Telesnitsky A
    Virology; 2006 Jul; 351(1):1-6. PubMed ID: 16777167
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Functional correlation between a novel amino acid insertion at codon 19 in the protease of human immunodeficiency virus type 1 and polymorphism in the p1/p6 Gag cleavage site in drug resistance and replication fitness.
    Brann TW; Dewar RL; Jiang MK; Shah A; Nagashima K; Metcalf JA; Falloon J; Lane HC; Imamichi T
    J Virol; 2006 Jun; 80(12):6136-45. PubMed ID: 16731952
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Real-time PCR quantification of genital shedding of herpes simplex virus (HSV) and human immunodeficiency virus (HIV) in women coinfected with HSV and HIV.
    Legoff J; Bouhlal H; Grésenguet G; Weiss H; Khonde N; Hocini H; Désiré N; Si-Mohamed A; de Dieu Longo J; Chemin C; Frost E; Pépin J; Malkin JE; Mayaud P; Bélec L
    J Clin Microbiol; 2006 Feb; 44(2):423-32. PubMed ID: 16455895
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Insertions in the human immunodeficiency virus type 1 protease and reverse transcriptase genes: clinical impact and molecular mechanisms.
    Winters MA; Merigan TC
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2575-82. PubMed ID: 15980322
    [No Abstract]   [Full Text] [Related]  

  • 76. Increased multinucleoside drug resistance and decreased replicative capacity of a human immunodeficiency virus type 1 variant with an 8-amino-Acid insert in the reverse transcriptase.
    van der Hoek L; Back N; Jebbink MF; de Ronde A; Bakker M; Jurriaans S; Reiss P; Parkin N; Berkhout B
    J Virol; 2005 Mar; 79(6):3536-43. PubMed ID: 15731248
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Molecular mechanisms of tenofovir resistance conferred by human immunodeficiency virus type 1 reverse transcriptase containing a diserine insertion after residue 69 and multiple thymidine analog-associated mutations.
    White KL; Chen JM; Margot NA; Wrin T; Petropoulos CJ; Naeger LK; Swaminathan S; Miller MD
    Antimicrob Agents Chemother; 2004 Mar; 48(3):992-1003. PubMed ID: 14982794
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of dipeptide insertions between codons 69 and 70 of human immunodeficiency virus type 1 reverse transcriptase on primer unblocking, deoxynucleoside triphosphate inhibition, and DNA chain elongation.
    Meyer PR; Lennerstrand J; Matsuura SE; Larder BA; Scott WA
    J Virol; 2003 Mar; 77(6):3871-7. PubMed ID: 12610164
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Insertions in the reverse transcriptase increase both drug resistance and viral fitness in a human immunodeficiency virus type 1 isolate harboring the multi-nucleoside reverse transcriptase inhibitor resistance 69 insertion complex mutation.
    Quiñones-Mateu ME; Tadele M; Parera M; Mas A; Weber J; Rangel HR; Chakraborty B; Clotet B; Domingo E; Menéndez-Arias L; Martínez MA
    J Virol; 2002 Oct; 76(20):10546-52. PubMed ID: 12239335
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Genotypic testing for human immunodeficiency virus type 1 drug resistance.
    Shafer RW
    Clin Microbiol Rev; 2002 Apr; 15(2):247-77. PubMed ID: 11932232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.